Matt Wetzel and William Jackson, Life Sciences and Complex Litigation & Dispute Resolution partners in Goodwin's Washington, DC office, explore the impending decision in a recent federal lawsuit brought by Pfizer in this byline. Pfizer is challenging federal government limits on drug makers’ ability to offer assistance to help the uninsured and underinsured, including Medicare and Medicaid beneficiaries, obtain prescription medications that may be otherwise too expensive for them. Read the byline here.